K. Innos

Most-cited papers

1. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

   Haidong Mohsen Christine Ryan M Zulfiqar A Austin Daniel C Wang Naghavi Allen Barber Bhutta Carter Casey Char, Haidong Wang, M. Naghavi, Christine A. Allen +496 more

   2016The Lancet5,403 citations Open access

   Semantic Scholar

   Save

2. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

   M. Forouzanfar, Lily T. Alexander, H. R. Anderson, Victoria F. Bachman +496 more

   2015The Lancet1,491 citations Open access

   Semantic Scholar

   Save

3. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

   C. Fitzmaurice, D. Abate, Naghmeh Abbasi, H. Abbastabar +496 more

   2019JAMA Oncology1,369 citations Open access

   Semantic Scholar

   Save

4. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016

   C. Fitzmaurice, T. Akinyemiju, F. A. Al Lami, Tahiya Alam +149 more

   2018JAMA Oncology1,125 citations Open access

   Semantic Scholar

   Save

5. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

   Nancy Jamal Solomon M Cristiana Foad Jemal Ahmed Zegeye Fullman Yearwood Abay Abbafati Abd-Allah Abdela Ab, N. Fullman, J. Yearwood, S. Abay +496 more

   2018The Lancet856 citations Open access

   Semantic Scholar

   Save

6. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015

   Haidong Tim M Austin Grant Hmwe Hmwe Emmanuela Simon I Edw Wang Wolock Carter Nguyen Kyu Gakidou Hay Mills Tr, Haidong Wang, Timothy M. Wolock, A. Carter +451 more

   2016The Lancet HIV597 citations Open access

   Semantic Scholar

   Save

7. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.

   Rafael Cardoso, Feng Guo, T. Heisser, M. Hackl +52 more

   2021The Lancet Oncology382 citations Open access

   Semantic Scholar

   Save

8. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

   S. Safiri, S. Sepanlou, Kevin S. Ikuta, Catherine Bisignano +245 more

   2019The Lancet Gastroenterology and Hepatology316 citations Open access

   Semantic Scholar

   Save

9. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017

   Lisa M. Force, Ibrahim Abdollahpour, S. Advani, D. Agius +167 more

   2019The Lancet Oncology291 citations Open access

   Semantic Scholar

   Save

10. Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.

    M. Sant, M. Chirlaque López, R. Agresti, M. S. Sánchez Pérez +10 more

    2015European Journal of Cancer264 citations Open access

    Semantic Scholar

    Save

11. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

    Elysia M Lisa M Rixing Kelly Dan Hannah Jacqueline Jonath Alvarez Force Xu Compton Lu Henrikson Kocarnik Har, Elysia M. Alvarez, Lisa M. Force, Rixing Xu +496 more

    2021The Lancet Oncology188 citations Open access

    Semantic Scholar

    Save

12. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.

    L. Botta, G. Gatta, R. Capocaccia, C. Stiller +10 more

    2022The Lancet Oncology154 citations Open access

    Semantic Scholar

    Save

13. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 - Results from the EUROCARE-5 study.

    B. Holleczek, S. Rossi, Agius Domenic, K. Innos +5 more

    2015European Journal of Cancer127 citations

    Semantic Scholar

    Save

14. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017

    L. S. Vestergaard, J. Nielsen, T. Krause, L. Espenhain +33 more

    2017Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin123 citations Open access

    Semantic Scholar

    Save

15. European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?

    J. Nielsen, L. S. Vestergaard, L. Richter, D. Schmid +42 more

    2019Clinical Microbiology and Infection120 citations Open access

    Semantic Scholar

    Save

16. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study.

    E. Crocetti, S. Mallone, T. Robsahm, A. Gavin +203 more

    2015European Journal of Cancer103 citations Open access

    Semantic Scholar

    Save

17. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.

    R. de Angelis, E. Demuru, P. Baili, X. Troussard +15 more

    2024The Lancet Oncology99 citations Open access

    Semantic Scholar

    Save

18. Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014

    K. Ojamaa, K. Innos, A. Baburin, H. Everaus +1 more

    2018BMC Cancer51 citations Open access

    Semantic Scholar

    Save

19. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.

    P. Minicozzi, K. Innos, M. Sánchez, A. Trama +146 more

    2017European Journal of Cancer46 citations

    Semantic Scholar

    Save

20. Sex differences in cancer survival in Estonia: a population-based study

    K. Innos, P. Padrik, V. Valvere, T. Aareleid

    2015BMC Cancer41 citations Open access

    Semantic Scholar

    Save

21. The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017

    A. Etemadi, Saeid Safiri, S. Sepanlou, Kevin S. Ikuta +182 more

    2019The Lancet Gastroenterology and Hepatology40 citations Open access

    Semantic Scholar

    Save

22. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer

    P. Minicozzi, L. V. Van Eycken, F. Molinié, K. Innos +13 more

    2019International Journal of Cancer39 citations Open access

    Semantic Scholar

    Save

23. Survival of European adolescents and young adults diagnosed with cancer in 2010-2014.

    A. Trama, L. Botta, C. Stiller, O. Visser +16 more

    2024European Journal of Cancer37 citations Open access

    Semantic Scholar

    Save

24. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study

    P. Padrik, A. Valter, E. Valter, A. Baburin +1 more

    2017Acta oncologica30 citations Open access

    Semantic Scholar

    Save

25. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?

    P. Minicozzi, P. Walsh, M. Sánchez, A. Trama +7 more

    2018European Journal of Cancer25 citations

    Semantic Scholar

    Save

26. Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study

    T. Aareleid, M. Zimmermann, A. Baburin, K. Innos

    2017BMC Cancer25 citations Open access

    Semantic Scholar

    Save

27. Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries

    A. Bouvier, V. Jooste, R. Lillini, R. Marcos-Gragera +10 more

    2024International Journal of Cancer21 citations Open access

    Semantic Scholar

    Save

28. Methylene blue intra-arterial staining of resected colorectal cancer specimens improves accuracy of nodal staging: A randomized controlled trial.

    Heigo Reima, H. Saar, K. Innos, J. Soplepmann

    2016European Journal of Surgical Oncology21 citations

    Semantic Scholar

    Save

29. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia

    P. Veerus, R. Hallik, J. Jänes, Kai Jõers +3 more

    2021Journal of Medical Screening17 citations

    Semantic Scholar

    Save

30. Childhood cancer incidence and survival trends in Estonia (1970–2016): a nationwide population-based study

    K. Paapsi, A. Baburin, S. Mikkel, M. Mägi +2 more

    2020BMC Cancer16 citations Open access

    Semantic Scholar

    Save

31. Patterns of survival and surgical treatment in lung cancer patients in Estonia by histologic type and stage, 1996–2016

    K. Innos, K. Oselin, T. Laisaar, T. Aareleid

    2019Acta oncologica16 citations Open access

    Semantic Scholar

    Save

32. Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine

    A. Patašius, K. Innos, A. Barchuk, Anton Ryzhov +4 more

    2019BMJ Open16 citations Open access

    Semantic Scholar

    Save

33. The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer

    O. Kurtenkov, K. Innos, B. Sergejev, K. Klaamas

    2018BioMed Research International16 citations Open access

    Semantic Scholar

    Save

34. Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening.

    K. Innos, Heigo Reima, A. Baburin, K. Paapsi +2 more

    2018Cancer Epidemiology16 citations

    Semantic Scholar

    Save

35. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.

    P. Minicozzi, M. Vicentini, K. Innos, C. Castro +74 more

    2020European Journal of Surgical Oncology14 citations Open access

    Semantic Scholar

    Save

36. Increasing kidney cancer incidence and survival in Estonia: role of age and stage

    K. Innos, T. Sepp, A. Baburin, A. Kotsar +3 more

    2018Acta oncologica14 citations Open access

    Semantic Scholar

    Save

37. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet).

    L. Locati, S. Cavalieri, L. Dal Maso, S. Busco +17 more

    2020Oral Oncology13 citations Open access

    Semantic Scholar

    Save

38. Survival and Health Care Burden of Children With Retinoblastoma in Europe.

    Gianni Virgili, R. Capocaccia, L. Botta, D. Bennett +15 more

    2024JAMA ophthalmology12 citations Open access

    Semantic Scholar

    Save

39. Gastric cancer trends in Estonia 1995–2014 by age, subsite, morphology and stage

    Maris Pärn, K. Innos, A. Baburin, R. Kiivet +1 more

    2019Acta oncologica12 citations Open access

    Semantic Scholar

    Save

40. Prostate cancer incidence, mortality and survival trends in Estonia, 1995–2014

    K. Innos, A. Baburin, A. Kotsar, Ivar-Endrik Eiche +1 more

    2017Scandinavian journal of urology12 citations Open access

    Semantic Scholar

    Save

41. Age-specific cancer survival in Estonia: recent trends and data quality

    K. Innos, K. Lang, K. Pärna, T. Aareleid

    2015Clinical Epidemiology12 citations Open access

    Semantic Scholar

    Save

42. Quality Assessment of Cervical Cytology Practices in Estonia From 2007 to 2018

    Madleen Orumaa, K. Innos, M. Suurna, L. Salumäe +1 more

    2022Cancer Control: Journal of the Moffitt Cancer Cente11 citations Open access

    Semantic Scholar

    Save

43. Effect of Pap-smear and sociodemographic factors on cervical cancer risk in Estonia: A population-based case-control study.

    O. Nõmm, P. Veerus, Madleen Orumaa, K. Innos

    2022Cancer Epidemiology11 citations

    Semantic Scholar

    Save

44. Perceived Stress During the First Wave of COVID-19 Outbreak: Results From Nationwide Cross-Sectional Study in Estonia

    R. Reile, Lembe Kullamaa, R. Hallik, K. Innos +5 more

    2021Frontiers in Public Health11 citations Open access

    Semantic Scholar

    Save

45. Incidence and Survival for Head and Neck Cancers in Estonia, 1996–2016: A Population-Based Study

    S. Kase, A. Baburin, M. Kuddu, K. Innos

    2021Clinical Epidemiology11 citations Open access

    Semantic Scholar

    Save

46. Recent changes in breast cancer incidence and mortality in Estonia: Transition to the west

    A. Baburin, T. Aareleid, M. Rahu, Lauri Reedik +1 more

    2016Acta oncologica11 citations Open access

    Semantic Scholar

    Save

47. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.

    M. Sant, C. Vener, R. Lillini, S. Rossi +16 more

    2024The Lancet Oncology10 citations

    Semantic Scholar

    Save

48. Health-Related Quality of Life and Its Socio-Demographic and Behavioural Correlates during the COVID-19 Pandemic in Estonia

    Merili Tamson, R. Reile, Diana Sokurova, K. Innos +3 more

    2022International Journal of Environmental Research and Public Health10 citations Open access

    Semantic Scholar

    Save

49. Cervical cancer screening history among women diagnosed with cervical cancer in Estonia 2017–18

    Madleen Orumaa, K. Innos, M. Suurna, P. Veerus

    2022European Journal of Public Health9 citations Open access

    Semantic Scholar

    Save

50. Epithelial head and neck cancer survival in Europe: Geographical variation, time trends and long term survival.

    G. Gatta, S. Lüttmann, A. Trama, S. Rossi +7 more

    2025European Journal of Cancer8 citations

    Semantic Scholar

    Save